Neuroleptic malignant syndrome in the acquired immunodeficiency syndrome

Postgraduate Medical Journal

Volumn 73, Issue 866, 1997, Pages 779-784

  Hernández, José L ^a   Palacios Araus, Luis ^a   Echevarria, Santiago ^a   Herrán, Andrés ^a   Campo, Juan F ^a   Riancho, José A ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Acquired immunodeficiency syndrome; Antipsuchotic agents; Neuroleptic malignant syndome

Indexed keywords

BENZODIAZEPINE; BROMOCRIPTINE; DANTROLENE; DROPERIDOL; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; PROCHLORPERAZINE; THIETHYLPERAZINE; TRIMETHOBENZAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; ELECTROCONVULSIVE THERAPY; FEVER; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PROGNOSIS; PSYCHOSIS;

EID: 0030697906     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.866.779     Document Type: Article

References (32)

1. Smego Jr RA, Durack DT. The neuroleptic malignant syndrome. Arch Intern Med 1982; 142: 1183-5.
2. Delay J, Deniker P. Drug-induced extrapyramidal syndromes. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, Vol 6. Diseases of the basal ganglia. Amsterdam: North-Holland Publishing, 1968; pp 248-66.
3. Bernstein WB, Scherokman B. Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome. Acta Neurol Scand 1986; 73: 636-7.
4. Breitbart W, Marotta RF, Call P. AIDS and neuroleptic malignant syndrome (letter). Lancet 1988; 31: 1488-9.
5. Manser TJ, Warner JF. Neuroleptic malignant syndrome associated with prochlorperazine. South Med J 1990; 83: 73-4.
6. Edelstein HE, Chirurgi VA, Gloudeman MW, Beckley DJ, McCabe RE. Adverse reactions to phenothiazine antiemetics in AIDS. DICP 1991; 25: 1007.
7. Burch EA Jr, Montoya J. Neuroleptic malignant syndrome in an AIDS patient (letter). J Clin Psychopharmacol 1989; 9: 228-9.
8. Gabellini AS, Pezzoli A, De Massis P, Casadei G, Grillo A, Sacquegna T. Neuroleptic malignant syndrome in an AIDS patient: clinical and pathological findings. Ital J Neurol Sci 1994; 15: 293-5.
9. Lazarus A. EPS, NMS, and AIDS (letter). Biol Psychiatry 1990; 28: 551-2.
10. De la Cour J. Neuroleptic malignant syndrome: do we know enough?. J Adv Nun 1995; 21: 897-904.
11. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77: 185-202.
12. Guzé BH, Baxter Jr LR. Neuroleptic malignant syndrome. N Engl J Med 1985; 313: 163-6.
13. Perry SW. Organic mental disorders caused by HIV: update on early diagnosis and treatment. Am J Psychiatry 1990; 147: 696-710.
14. Nath A, Jankovic J, Pettigrew C. Movement disorders and AIDS. Neurology 1987; 37: 37-41.
15. Reyes MG, Feraldi F, Senseng CS, Fariello R. Nigral degeneration in acquired immunodeficiency syndrome (AIDS) (abstract). Neurology 1989; 39 (suppl 1): 427.
16. Martinez E, Domingo P, Lloret J. Sindrome neuroléptico maligno. Med Clin (Barcelona) 1994; 102: 181-8.
17. Naganuma H, Fujii I. Incidence and risk factors in neuroleptic malignant syndrome. Acta Psychiatr Scand 1994; 90: 424-6.
18. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137-45.
19. Buckley PF, Hutchinson M. Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry 1995; 58: 271-3.
20. Jee A, Sing S, Singh G, Ong S. Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry 1988; 153: 107-11.
21. Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986; 143: 1227-33.
22. Diagnostic and statistical manual for mental disorders. Fourth edition (DSM-IV). Washington DC: American Psychiatric Press, 1994; pp739-42.
23. Shalev A, Munitz H. The neuroleptic malignant syndrome:agent and host interaction. Acta Psychiatr Scand 1986; 73: 337-47.
24. Goeke JE, Hagan DS, Goelzer SL, Coursin DB. Lethal catatonia complicated by the development of neuroleptic malignant syndrome in a middle - aged female. Crit Care Med 1991; 19: 1445-8.
25. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995; 45: 219-24.
26. Brown TM, Skop BP, Mareth TR. Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 1996; 30: 527-33.
27. Ames D, Wirshing WC. Ectasy, the serotonin syndrome, and neuroleptic malignant syndrome - a possible link? (letter) JAMA 1993; 269: 869.
28. Nimmo SM, Kennedy BW, Tullet WM, Blyth AS, Dougall JR. Drug-induced hyperthermia. Anaesthesia 1993; 48: 892-5.
29. Daras M, Kakkouras L, Tuchman AJ, Koppel BS. Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? Acta Neurol Scand 1995; 92: 161-5.
30. Berger JR, Levy RM. The neurological complications of acquired immunodeficiency virus infection. Med Clin North Am 1993; 77: 1-23.
31. Carrazana EJ, Rossitch E Jr, Samuels MA. Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry 1989; 52: 1445-7.
32. Davis JM, Janicak PG, Sakkas P, Gilmor C, Wang Z. Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convuls Ther 1991; 7: 111-20.